| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.07 | 0.2 |